Therefore, a crucial role was demonstrated for the HMGA2–miRNA-200c-3p–LSAMP–Wnt pathway in the immune response to colorectal cancer, with significant implications for improved therapeutic responses [57]. This evidence concerns the gene LSAMP and colorectal cancer.